CD39L2 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD39L2 monoclonal antibodies for research in understanding CD39L2's role in various biological processes. CD39L2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD39L2, also known as ecto-nucleotide triphosphate diphosphohydrolase-1, plays a crucial role in regulating extracellular nucleotide levels, which are important for cellular signaling and immune responses. By hydrolyzing ATP and ADP, CD39L2 contributes to the modulation of inflammation and the maintenance of tissue homeostasis. Understanding CD39L2 function is vital for elucidating potential implications in various diseases, including cancer and autoimmune disorders. CD39L2 monoclonal antibodies enable precise detection and characterization of CD39L2 expression patterns across different tissues and cell types. Researchers can investigate CD39L2's involvement in cellular pathways and molecular interactions through multiple experimental approaches. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by facilitating detailed studies of CD39L2's role in health and disease.